Celldex Therapeutics CLDX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's operating lease right-of-use assets in other assets?
- Celldex Therapeutics (CLDX) reported operating lease right-of-use assets in other assets of $2.01M in Q1 2026.
- How has Celldex Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Celldex Therapeutics's operating lease right-of-use assets in other assets decreased by 42.7% year-over-year, from $3.51M to $2.01M.
- What is the long-term trend for Celldex Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Celldex Therapeutics's operating lease right-of-use assets in other assets has grown at a -6.7% compound annual growth rate (CAGR), from $3.45M to $2.44M.